Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 468563019 | Betamethasone+salicylic acid 0.05/3% ointment | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 721426011 | Betamethasone+salicylic acid 0.05/3% ointment (substance) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1192588019 | Betamethasone+salicylic acid 0.05/3% ointment (product) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3692869013 | Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3692870014 | Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3692871013 | Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3613481000052113 | betametason 0,05 % + salicylsyra 3 %, salva | sv | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| 4587691000052113 | betametason (som betametasondipropionat) 500 mikrogram/gram och salicylsyra 30 milligram/gram, kutan salva | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Is a | Product containing betamethasone and salicylic acid (medicinal product) | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has active ingredient | Betamethasone | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has active ingredient | Adrenal hormone | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has active ingredient | binjurehormonmedel | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has active ingredient | Salicylic acid (substance) | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has active ingredient | keratolytiskt medel | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has active ingredient | lokal produkt eller lokalt medel | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has manufactured dose form | kutan och/eller transdermal läkemedelsform | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has manufactured dose form | Ointment | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Is a | betametason för lokalt bruk | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Is a | salicylsyra för lokalt bruk | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has manufactured dose form | Cutaneous ointment | true | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 1 | |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 2 | |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | räkning av bas i aktiv ingrediens | två | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has basis of strength substance (attribute) | Betamethasone | true | Inferred relationship | Some | 1 | |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | har täljarvärde för koncentrationsstyrka | 30 | false | Inferred relationship | Some | 2 | |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | har täljarvärde för koncentrationsstyrka | 500 | false | Inferred relationship | Some | 1 | |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has basis of strength substance (attribute) | Salicylic acid (substance) | true | Inferred relationship | Some | 2 | |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has precise active ingredient | Salicylic acid (substance) | true | Inferred relationship | Some | 2 | |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has precise active ingredient | Betamethasone dipropionate | true | Inferred relationship | Some | 1 | |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Is a | Betamethasone and salicylic acid only product in cutaneous dose form | true | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Plays role | Antifungal therapeutic role (role) | true | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Is a | Product containing glucocorticoid (product) | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Is a | Product containing fluorinated corticosteroid (product) | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Is a | Product containing pregnane (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR